Crossref journal-article
Oxford University Press (OUP)
Human Molecular Genetics (286)
Bibliography

Ehrnhoefer, D. E., Duennwald, M., Markovic, P., Wacker, J. L., Engemann, S., Roark, M., Legleiter, J., Marsh, J. L., Thompson, L. M., Lindquist, S., Muchowski, P. J., & Wanker, E. E. (2006). Green tea (−)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington’s disease models. Human Molecular Genetics, 15(18), 2743–2751.

Authors 12
  1. Dagmar E. Ehrnhoefer (first)
  2. Martin Duennwald (additional)
  3. Phoebe Markovic (additional)
  4. Jennifer L. Wacker (additional)
  5. Sabine Engemann (additional)
  6. Margaret Roark (additional)
  7. Justin Legleiter (additional)
  8. J. Lawrence Marsh (additional)
  9. Leslie M. Thompson (additional)
  10. Susan Lindquist (additional)
  11. Paul J. Muchowski (additional)
  12. Erich E. Wanker (additional)
References 32 Referenced 337
  1. 10.1016/0092-8674(93)90585-E / Cell / A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes by The Huntington's Disease Collaborative Research Group (1993)
  2. 10.1016/S0968-0004(03)00168-3 / Trends Biochem. Sci. / The hunt for huntingtin function: interaction partners tell many different stories by Harjes (2003)
  3. {'key': 'key\n\t\t\t\t20171012164354_DDL210C3', 'first-page': '16', 'article-title': 'Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36–39 repeats', 'volume': '59', 'author': 'Rubinsztein', 'year': '1996', 'journal-title': 'Am. J. Hum. Genet.'} / Am. J. Hum. Genet. / Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36–39 repeats by Rubinsztein (1996)
  4. 10.1097/00005072-198511000-00003 / J. Neuropathol. Exp. Neurol. / Neuropathological classification of Huntington's disease by Vonsattel (1985)
  5. 10.1126/science.277.5334.1990 / Science / Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain by DiFiglia (1997)
  6. 10.1016/S0092-8674(00)80623-6 / Cell / Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease by Yamamoto (2000)
  7. 10.1212/01.wnl.0000192103.24796.42 / Neurology / Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis by Glabe (2006)
  8. 10.1038/nrn1806 / Nat. Rev. Neurosci. / Normal huntingtin function: an alternative approach to Huntington's disease by Cattaneo (2005)
  9. 10.1016/j.jmb.2004.07.054 / J. Mol. Biol. / Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display by Colby (2004)
  10. 10.1073/pnas.110138997 / Proc. Natl Acad. Sci. USA / Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy by Heiser (2000)
  11. 10.1038/ng864 / Nat. Genet. / A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila by Kazantsev (2002)
  12. 10.1074/jbc.275.14.10437 / J. Biol. Chem. / Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening by Nagai (2000)
  13. 10.1073/pnas.0408936102 / Proc. Natl Acad. Sci. USA / A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo by Zhang (2005)
  14. 10.1073/pnas.182426599 / Proc. Natl Acad. Sci. USA / Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay by Heiser (2002)
  15. 10.2174/138161206777698828 / Curr. Pharm. Des / Therapeutic approaches to polyglutamine diseases: combating protein misfolding and aggregation by Herbst (2006)
  16. 10.1023/A:1007614613771 / Eur. J. Epidemiol. / Intake of flavonoids and risk of dementia by Commenges (2000)
  17. 10.1159/000085385 / Neurosignals / Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway by Mandel (2005)
  18. 10.1016/S0092-8674(00)80513-9 / Cell / Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation by Davies (1997)
  19. 10.1093/carcin/19.10.1771 / Carcinogenesis / Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue by Suganuma (1998)
  20. 10.1038/nsmb860 / Nat. Struct. Mol. Biol. / Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer by Wacker (2004)
  21. 10.1016/j.molcel.2004.06.029 / Mol. Cell. / Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation by Schaffar (2004)
  22. 10.1016/S0361-9230(01)00599-8 / Brain Res. Bull. / New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins by Ko (2001)
  23. 10.1083/jcb.200112104 / J. Cell Biol. / Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1 by Meriin (2002)
  24. 10.1016/S0076-6879(99)09026-6 / Meth. Enzymol. / Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates by Wanker (1999)
  25. 10.1073/pnas.0500055102 / Proc. Natl Acad. Sci. USA / Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila by Agrawal (2005)
  26. 10.1093/ajcn/80.6.1558 / Am. J. Clin. Nutr. / Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement by Henning (2004)
  27. 10.1074/jbc.M205809200 / J. Biol. Chem. / Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrillization by Poirier (2002)
  28. 10.1515/BC.2000.114 / Biol. Chem. / Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations by Wanker (2000)
  29. 10.1111/j.1432-1033.1994.tb18574.x / Eur. J. Biochem. / Study of the interaction between salivary proline-rich proteins and a polyphenol by 1H-NMR spectroscopy by Murray (1994)
  30. 10.1038/nrd769 / Nat. Rev. Drug Discov. / Therapeutic strategies for human amyloid diseases by Sacchettini (2002)
  31. 10.1073/pnas.140202897 / Proc. Natl Acad. Sci. USA / Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils by Muchowski (2000)
  32. 10.1016/j.jcis.2004.05.009 / J. Colloid Interface Sci. / AFM studies of astrocyte-secreted apolipoprotein E- and J-containing lipoproteins. by Legleiter (2004)
Dates
Type When
Created 19 years ago (Aug. 7, 2006, 8:13 p.m.)
Deposited 6 years, 4 months ago (April 20, 2019, 11 a.m.)
Indexed 2 weeks, 2 days ago (Aug. 12, 2025, 6:01 p.m.)
Issued 19 years ago (Aug. 7, 2006)
Published 19 years ago (Aug. 7, 2006)
Published Online 19 years ago (Aug. 7, 2006)
Published Print 18 years, 11 months ago (Sept. 15, 2006)
Funders 0

None

@article{Ehrnhoefer_2006, title={Green tea (−)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington’s disease models}, volume={15}, ISSN={0964-6906}, url={http://dx.doi.org/10.1093/hmg/ddl210}, DOI={10.1093/hmg/ddl210}, number={18}, journal={Human Molecular Genetics}, publisher={Oxford University Press (OUP)}, author={Ehrnhoefer, Dagmar E. and Duennwald, Martin and Markovic, Phoebe and Wacker, Jennifer L. and Engemann, Sabine and Roark, Margaret and Legleiter, Justin and Marsh, J. Lawrence and Thompson, Leslie M. and Lindquist, Susan and Muchowski, Paul J. and Wanker, Erich E.}, year={2006}, month=aug, pages={2743–2751} }